Evidence map›Paper›PMID 40812612›Full record

ArticleActa biomaterialia2025

Chlorocatechol-functionalized gelatin nanoparticles as a hemostatic agent with antimicrobial properties.

Fatemeh Razaviamri, James Manuel, Kan Wang, Zhongtian Zhang, Bruce P Lee

Abstract read
In one paragraph

Article in Acta biomaterialia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fatemeh RazaviamriDepartment of Biomedical Engineering, Michigan Technological University, Houghton, Michigan 49931, United States.
James ManuelDepartment of Biomedical Engineering, Michigan Technological University, Houghton, Michigan 49931, United States.
Kan WangDepartment of Biomedical Engineering, Michigan Technological University, Houghton, Michigan 49931, United States.
Zhongtian ZhangDepartment of Biomedical Engineering, Michigan Technological University, Houghton, Michigan 49931, United States.
Bruce P LeeDepartment of Biomedical Engineering, Michigan Technological University, Houghton, Michigan 49931, United States. Electronic address: bplee@mtu.edu.

Funding

Mutlifunctional Nanocomposite Bioadhesive for Diabetic Wound RepairR15GM135875 · NIGMS · MICHIGAN TECHNOLOGICAL UNIVERSITY · PI LEE, BRUCE P · 2020 to 2024
$884k
NIGMS NIH HHS R15 GM135875
6 · The paper itself

Abstract

Hemorrhage is one of the leading preventable causes of death associated with trauma, which is often complicated by wound infection. Current hemostatic materials are not ideal and lack antimicrobial properties needed for infection prevention. Here, we tested the feasibility for 6-chlorodopamine-functionalized gelatin (GDC) nanoparticles to function as a hemostatic powder with strong tissue adhesion and antibacterial properties. 6-Chlorodopamine contains a catechol sidechain that is further modified with an electron withdrawing chlorine atom, and provides strong tissue adhesion and antimicrobial property. These gelatin nanoparticles are not covalently crosslinked, which enablde them to rapidly transition into an adhesive film when hydrated with an aqueous solution or blood. The chlorination of catechol significantly increased structural integrity, interfacial bonding to tissue surface, and the rate of film formation. Additionally, GDC nanoparticles are noncytotoxic and nonhemolytic, and effectively killed Gram-positive (Staphylococcus epidermidis, Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria. Finally, GDC nanoparticles achieved significantly faster hemostasis and reduced blood loss when compared to a commercial fibrin glue, Tisseel, in tail transection and liver hemorrhage models performed in mice. These findings highlight the potential of GDC nanoparticle as a versatile, multifunctional hemostatic agent capable of both rapid hemorrhage control and infection prevention. STATEMENT OF SIGNIFICANCE: Existing hemostatic agents often lack effective antimicrobial properties and may not be suited for application in a prehospital setting. This work evaluated a multifunctional, hemostatic nanoparticle that addresses key challenges in hemorrhage control and infection prevention, through a simple, bioinspired formulation. Gelatin nanoparticles were functionalized with chlorocatechol (GDC) that can rapidly transition into adhesive films when hydrated with blood. Chlorocatechol imparted the nanoparticles with strong tissue adhesion, film integrity, and antimicrobial property. In mouse hemorrhage models, GDC significantly reduced blood loss and bleeding time when compared to a commercial fibrin sealant. This powder-form material requires no mixing or specialized equipment to deploy, which makes it potentially suitable for application in a prehospital setting.

Indexed as

Anti-Infective AgentsCatecholsGelatinHemostaticsNanoparticlesAnimalsHemorrhageHumansMiceAnti-Infective AgentsCatecholsGelatinHemostaticsAntibacterialBioadhesiveChlorocatecholHemostatic nanoparticles

Identifiers

PMID40812612
PMCPMC12368770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.